Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
暂无分享,去创建一个
[1] B. Walker,et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. , 1996, AIDS research and human retroviruses.
[2] M. Nowak,et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Sprent,et al. CD40 Ligand-Mediated Interactions Are Involved in the Generation of Memory CD8+ Cytotoxic T Lymphocytes (CTL) but Are Not Required for the Maintenance of CTL Memory following Virus Infection , 1998, Journal of Virology.
[4] M. Carrington,et al. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV‐1 infection , 1998, AIDS.
[5] D. Krakauer,et al. T–cell induced pathogenesis in HIV: bystander effects and latent infection , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[6] E. Rosenberg,et al. HIV type 1-specific helper T cells: a critical host defense. , 1998, AIDS research and human retroviruses.
[7] D. Richman,et al. Drug resistance in viruses. , 1994, Trends in microbiology.
[8] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[9] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[10] M A Nowak,et al. The role of antigen-independent persistence of memory cytotoxic T lymphocytes. , 2000, International immunology.
[11] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[12] L. Weinberger,et al. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.
[13] A S Perelson,et al. T cell repertoires and competitive exclusion. , 1994, Journal of theoretical biology.
[14] Martin A. Nowak,et al. Dynamics of cytotoxic T–lymphocyte exhaustion , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[15] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[16] J. Christensen,et al. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. , 1998, Journal of immunology.
[17] B. M. Flynn,et al. Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment , 2000, Journal of Virology.
[18] D. Krakauer,et al. Defining CTL-induced pathology: implications for HIV. , 2000, Virology.
[19] B. Walker,et al. Characterization of HIV-1-specific T-helper cells in acute and chronic infection. , 1999, Immunology letters.
[20] J. Mellors,et al. Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.
[21] R. Zinkernagel. Immune Protection vs. Immunopathology vs. Autoimmunity: A Question of Balance and of Knowledge , 1993, Brain pathology.
[22] J. Christensen,et al. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. , 1996, Journal of immunology.
[23] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[24] A. Trkola,et al. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. , 1999, The Journal of clinical investigation.
[25] Martin A. Nowak,et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.
[26] E. Rosenberg,et al. Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.
[27] Spyros A. Kalams,et al. The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses , 1998, The Journal of experimental medicine.
[28] A. Kermode,et al. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. , 1996, Virology.
[29] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[30] P. Klenerman,et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] B. Walker,et al. Levels of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Effector and Memory Responses Decline after Suppression of Viremia with Highly Active Antiretroviral Therapy , 1999, Journal of Virology.
[32] Dominik Wodarz,et al. CD8 memory, immunodominance, and antigenic escape , 2000, European journal of immunology.
[33] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[34] B. Walker,et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. , 1996, Journal of immunology.
[35] J. Oxford,et al. Drug resistance in viruses, other microbes and eukaryotes. , 1987, Journal of Antimicrobial Chemotherapy.
[36] M. Nowak,et al. Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.
[37] Stephen W. Martin,et al. Cytotoxic T Lymphocytes , 1988 .
[38] J. Lisziewicz,et al. Control of HIV despite the discontinuation of antiretroviral therapy. , 1999, The New England journal of medicine.
[39] M. Nowak,et al. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection , 1997, Journal of virology.
[40] J. Condra,et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors , 1995, Nature.
[41] D. Richman,et al. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. , 1989, Science.
[42] Rolf M. Zinkernagel,et al. Immunology Taught by Viruses , 1996, Science.
[43] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[44] P. Borrow,et al. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response , 1996, The Journal of experimental medicine.
[45] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[46] N. Letvin. Progress in the development of an HIV-1 vaccine. , 1998, Science.